FITC Anti-Human CD16 Antibody[CB16]

The FITC Anti-Human CD16 Antibody[CB16] is a highly specific and reliable tool designed for the detection and analysis of CD16 expression in human samples. This antibody is conjugated with fluorescein isothiocyanate (FITC), a widely used fluorochrome known for its exceptional brightness and stability. With its exceptional performance, this antibody enables accurate and efficient identification of CD16-positive cells in various research applications.

The CD16 molecule, also known as FcγRIII, is a low-affinity receptor for the Fc region of immunoglobulin G (IgG). It is expressed on the surface of natural killer (NK) cells, macrophages, and a subset of T cells. CD16 plays a crucial role in mediating antibody-dependent cellular cytotoxicity (ADCC) and phagocytosis, making it an essential target for immunological studies.

The FITC Anti-Human CD16 Antibody[CB16] exhibits exceptional specificity and sensitivity, ensuring reliable and accurate results. It has been extensively validated for flow cytometry applications, providing researchers with a powerful tool for the identification and characterization of CD16-positive cells. This antibody is suitable for use in both research and clinical settings, enabling a wide range of applications, including immunophenotyping, cell sorting, and functional studies.

The FITC conjugation of this antibody offers several advantages. FITC is known for its high fluorescence intensity, allowing for easy detection and analysis of CD16 expression. Additionally, FITC is highly photostable, ensuring consistent and reliable results over time. The conjugation process has been carefully optimized to maintain the antibody's binding affinity and specificity, ensuring optimal performance in various experimental conditions.

In summary, the FITC Anti-Human CD16 Antibody[CB16] is a highly reliable and specific tool for the detection and analysis of CD16 expression. With its exceptional performance and versatility, this antibody is an invaluable asset for researchers and clinicians alike, facilitating a deeper understanding of immune cell function and contributing to advancements in immunotherapy and disease research.